Ritonavir

Protease Inhibitor, Cytochrome P450 3A Inhibitor

Brands

Kaletra
Norvir

Ritonavir Oral Solution

DosageBrandImage
lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral SolutionGeneric
lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra]Generic
ritonavir 80 MG/ML Oral SolutionGeneric
ritonavir 80 MG/ML Oral Solution [Norvir]Generic

Ritonavir Oral Tablet

DosageBrandImage
lopinavir 100 MG / ritonavir 25 MG Oral TabletGeneric
lopinavir 100 MG / ritonavir 25 MG Oral Tablet [Kaletra]Generic
lopinavir 200 MG / ritonavir 50 MG Oral TabletGeneric
lopinavir 200 MG / ritonavir 50 MG Oral Tablet [Kaletra]Generic
ritonavir 100 MG Oral TabletGeneric
ritonavir 100 MG Oral Tablet [Norvir]Generic

Ritonavir Oral Powder

DosageBrandImage
ritonavir 100 MG Oral PowderGeneric
ritonavir 100 MG Oral Powder [Norvir]Generic

Ritonavir desired effects:

  • Decreased Protein Synthesis
  • Increased Immunologically Active Molecule Activity

Ritonavir drug classes:

  • Protease Inhibitor
  • Cytochrome P450 3A Inhibitor

Ritonavir pharmacologic actions:

  • Cytochrome P-450 CYP3A Inhibitors
  • HIV Protease Inhibitors

Ritonavir mechanism of action:

  • UDP Glucuronosyltransferases Inducers
  • Cytochrome P450 2C19 Inducers
  • Cytochrome P450 2B6 Inducers
  • Cytochrome P450 3A4 Inhibitors
  • Cytochrome P450 3A Inhibitors
  • Breast Cancer Resistance Protein Inhibitors
  • HIV Protease Inhibitors
  • Cytochrome P450 2C9 Inducers
  • Cytochrome P450 1A2 Inducers
  • Cytochrome P450 2D6 Inhibitors
  • Cytochrome P450 3A Inducers
  • P-Glycoprotein Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 4/7/2024, 10:31:00 AM